Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Joseph A. Califano(UC San Diego Health System), Ivan Borrello(Johns Hopkins University), Kimberly Noonan(Johns Hopkins University), Ray Blanco(Greater Baltimore Medical Center), Donald T. Weed(University of Miami), Wayne M. Koch(Johns Hopkins University), Shanthi Marur(Johns Hopkins University), Nishant Agrawal(Johns Hopkins University), Jeremy D. Richmon(Johns Hopkins University), Steven N. Goodman(Johns Hopkins University), Carole Fakhry(Johns Hopkins University), Patrick K. Ha(University of California, San Francisco), Christine G. Gourin(Johns Hopkins University), Hao Wang(Tongji University), Zhe Zhang(Sun Yat-sen University), John Saunders(Greater Baltimore Medical Center), Mei San Tang(Greater Baltimore Medical Center), Marshall Levine(Greater Baltimore Medical Center), Geoffrey Neuner(Greater Baltimore Medical Center), Paolo Serafini(University of Miami), Lakshmi Rudraraju(Johns Hopkins University), Zubair Khan(Johns Hopkins University)
Cited by 184
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k